Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NORS for Plantar Warts
NCT05877313Phase 2Completed
- Sponsor
- SaNOtize
- Start
- Aug 2023
- Primary completion
- Feb 2024
- Modality
- DNA Intercalators/Alkylators, Inhalation Devices
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitric oxide in Plantar Wart (3 arms), sponsored by SaNOtize. Primary endpoint: Lesion Clearance at Day 35. Started Aug 2023; status: completed.
02
Drugs
nitric oxide
03
Conditions
Plantar Wart
Beyond the preview
Go deeper on NCT05877313.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05877313.